Home » Newsletters » BioWorld Science

BioWorld Science

Oct. 27, 2009

View Archived Issues

Phase II trials of JNJ-42160443 in various types of pain are under way

Potent in vitro antiviral activity of enterovirus capsid inhibitor V-073 supports future development

Roche presents results from third quarter of 2009

Recombinant adenovirus serotype 26 HIV-1 vaccine safe, immunogenic in humans

Canakinumab trials show efficacy in juvenile idiopathic arthritis and gouty arthritis

Pharming reports results from preclinical study of rhC1INH in ischemic brain injury

Phase I trial of recombinant human acid sphingomyelinase in type B Niemann-Pick disease reported

In vivo evaluation of the novel nAChR agonist PF-4888086 in models of antipsychotic activity

EMEA grants positive opinion for The Medicines Company's Angiox in PCI

MedImmune reports interim data from ongoing trials of LAIV 2009 H1N1 vaccine

Bone formation/resorption biomarkers predict response to Re-186 HEDP therapy in prostate cancer

Eisai and TSD Japan enter into agreement for denileukin diftitox in Japan

SuperGen and GSK to collaborate on novel epigenetic therapeutics

CXCR3 antagonists claimed by sanofi-aventis for rheumatoid arthritis

Janssen discloses MC-5 receptor ligands for treatment of dermatological conditions

Ohio State University developing AR ablating agents for treating prostate cancer

Cephalon to acquire BioAssets Development Corporation

Astellas terminates development of antihuman osteopontin antibody ASK-8007 in RA

Ablynx wins award for successfully progressing antithrombotic ALX-0081 to phase II

PTC Therapeutics initiates phase II clinical trial of ataluren in hemophilia

FDA committee to review Gilead's aztreonam for P. aeruginosa infection in CF

FDA grants emergency use authorization to BioCryst's peramivir for 2009 H1N1 influenza

Psynova Neurotech and RBM identify diagnostic biomarkers for schizophrenia

FDA grants marketing clearance to Axis-Shield's anti-CCP assay in RA

Prometheus Laboratories launches ProOncDx diagnostic cancer tests in U.S.

Popular Stories

Today's news in brief
BioWorld
BioWorld briefs for Dec. 5, 2025.
Today's news in brief
BioWorld MedTech
BioWorld MedTech briefs for Dec. 5, 2025.
Hippocratic loath? ‘Harm’ threat from ACIP’s proposed HBV shift
BioWorld
Individual liberty and choice vs. wider public health became one predictable hinge upon which swung the often-acerbic debates at the CDC’s Advisory Committee for...
Høeg appointment as acting CDER director tied to vaccine strategy?
BioWorld
After a more than 13-year period of stability with Janet Woodcock as the head of CDER, with Patrizia Cavazzoni taking charge during the next four years of former...
First phase of synthetic human genome project successfully completes
BioWorld
The first phase of the U.K. synthetic human genome project has successfully completed, realizing key steps in chromosome synthesis. The work has demonstrated a...